Henry Mugerwa
Henry Mugerwa publishes mostly in Infectious Diseases, Emergency Medicine and Virology, on topics such as HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment and HIV-related health complications and treatments.
- World rank
- #730,413 of 7,710,434 ranked researchers
- Rank in Uganda
- #336 of 3,724
- Works
- 76
- Citations
- 1.5k
- Citations per work
- 19.7
What does Henry Mugerwa research?
Henry Mugerwa's work is mostly in Medicine (72%), Immunology and Microbiology (8%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5471.5%
- Medicine5471.5%
- Everything else1418.3%
- Life Sciences810.2%
- 1Infectious Diseases49% of their works
- 2Emergency Medicine12% of their works
- 3Virology8% of their works
- 4Epidemiology5% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6Molecular Biology3% of their works
Research topics
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- HIV-related health complications and treatments
- HIV Research and Treatment
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Tuberculosis Research and Epidemiology
Which keywords describe Henry Mugerwa's research?
The keywords of their largest research topics: Antiretroviral Therapy, HIV Infection, Drug Resistance, HIV Transmission, Preexposure Prophylaxis, Integrase Inhibitors, Nucleoside Analogues and Immune Response.
- Pneumonia
- Mycobacterium tuberculosis
- Thrombosis
- Clinical Characteristics
- Diagnosis
- Antibodies
- ACE2 Receptor
- HIV
- Cardiovascular Disease
- Immune Response
- Integrase Inhibitors
- HIV Transmission
- HIV Infection
- Antiretroviral Therapy
- Drug Resistance
- Preexposure Prophylaxis
- Nucleoside Analogues
- Vaccine
- Inflammation
- Epidemiology
- AIDS
- SARS-CoV-2
- Treatment
- Coronavirus
- spike protein
- Pneumocystis
- Tuberculosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 27 words, with their numbers
- Antiretroviral Therapy1105 topics
- HIV Infection552 topics
- Drug Resistance382 topics
- HIV Transmission361 topic
- Preexposure Prophylaxis361 topic
- Integrase Inhibitors331 topic
- Nucleoside Analogues331 topic
- Immune Response263 topics
- Vaccine263 topics
- Cardiovascular Disease221 topic
- Inflammation221 topic
- HIV192 topics
- Epidemiology173 topics
- ACE2 Receptor142 topics
- AIDS141 topic
- Antibodies141 topic
- SARS-CoV-2142 topics
- Diagnosis102 topics
- Treatment102 topics
- Clinical Characteristics71 topic
- Coronavirus71 topic
- Thrombosis71 topic
- spike protein71 topic
- Mycobacterium tuberculosis51 topic
- Pneumocystis51 topic
- Pneumonia51 topic
- Tuberculosis51 topic
Where does Henry Mugerwa work?
Henry Mugerwa's main affiliation in the publication record is Joint Clinical Research Centre, Uganda.
How many publications and citations does Henry Mugerwa have?
OpenAlex counts 76 works and 1,495 citations for Henry Mugerwa, an h-index of 19, ranking #730,413 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Henry Mugerwa. Posts are plain text and can be reported.